University Of Cambridge is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Location
Cambridge, England, UK
Type
Public Research University
Website
[cam.ac.uk](https://www.cam.ac.uk)
The University of Cambridge is one of the world's oldest and most prestigious universities, with a renowned neuroscience community. The MRC Laboratory of Molecular Biology and Department of Neuroscience are global centers for protein aggregation and neurodegenerative disease research.
The MRC LMB, located in Cambridge, is a world-leading center for structural biology and protein science. Researchers there have made fundamental discoveries about protein folding, aggregation, and prion diseases.
- Dementia Research Institute: Interdisciplinary neurodegeneration research
- Brain Banks: Human tissue for research
- Clinical trials unit: Early-phase clinical studies
- Tau protein biology and pathology
- Alpha-synuclein and Lewy body disease
- Prion diseases and protein misfolding
- Structural biology of aggregation
- Drosophila models of neurodegeneration
- RNA mechanisms in disease
- Discovery of tau filaments in Alzheimer's disease (Micheal Goedert)
- Alpha-synuclein as Lewy body component
- Multiple tau isoforms and alternative splicing
- Propagation of protein aggregates
- Prion-like mechanisms in neurodegeneration
- Crystal structure of amyloid-beta
¶ Major Labs and Centers
| Lab/Center |
Focus |
Key Faculty |
| Goedert Lab |
Tau and alpha-synuclein |
Michel Goedert |
| Collinge Lab |
Prions and protein folding |
John Collinge |
| Spillantini Lab |
tauopathies |
Maria Grazia Spillantini |
| Mallucci Lab |
Protein homeostasis |
Giovanna Mallucci |
| Nature Neuroscience |
Publication venue |
Multiple faculty |
- Michel Goedert (MRC LMB): Tau, alpha-synuclein, neurodegeneration
- John Collinge (MRC LMB): Prion diseases, protein misfolding
- Maria Spillantini (Cambridge): tauopathies, FTD
- Giovanna Mallucci (Cambridge): Autophagy, protein clearance
Cambridge offers world-class training:
- PhD in Neuroscience
- MRC LMB PhD program
- Wellcome Trust PhD programs
- Clinical research training
- International summer schools
The institution maintains active research programs in neurodegenerative disease research across multiple departments and centers.
- Clinical trials for Alzheimer's and Parkinson's disease
- Longitudinal studies on cognitive aging
- Biomarker discovery and validation studies
- Genetic screening and counseling services
- Molecular mechanisms of neurodegeneration
- Protein aggregation and misfolding studies
- Neuroinflammation and glial biology
- Synaptic function and plasticity
The study of University Of Cambridge has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Goedert M, et al. (1988). Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. PMID:3134198
- Spillantini MG, et al. (1997). alpha-Synuclein in Lewy bodies. Nature. PMID:9197263
- Collinge J. (2001). Prion diseases of humans and animals. Science. PMID:11714411
- Frost B, et al. (2009).tau propagation as a neurodegenerative disease-like mechanism? Nat Rev Neurosci. PMID:19629168